Cite
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant
MLA
Wei Jiang, et al. “Third-Party CMV- and EBV-Specific T-Cells for First Viral Reactivation after Allogeneic Stem Cell Transplant.” Blood Advances, vol. 6, no. 17, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....73f0199bdb8451c8f58ed365c28815ba&authtype=sso&custid=ns315887.
APA
Wei Jiang, Leighton E. Clancy, Selmir Avdic, Gaurav Sutrave, Janine Street, Renee Simms, Helen M. McGuire, Ellis Patrick, Adam S. Chan, Georgia McCaughan, Nadav Myers, Kenneth P. Micklethwaite, Vicki Antonenas, Adrian G. Selim, David Ritchie, Caroline M. Bateman, Peter J. Shaw, Emily Blyth, & David J. Gottlieb. (2022). Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant. Blood Advances, 6(17).
Chicago
Wei Jiang, Leighton E. Clancy, Selmir Avdic, Gaurav Sutrave, Janine Street, Renee Simms, Helen M. McGuire, et al. 2022. “Third-Party CMV- and EBV-Specific T-Cells for First Viral Reactivation after Allogeneic Stem Cell Transplant.” Blood Advances 6 (17). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....73f0199bdb8451c8f58ed365c28815ba&authtype=sso&custid=ns315887.